Klinika Za Infektivne Bolesti Dr. Fran Mihaljevic
- Address
- lock Available on a paid plan
Oral Antibiotic Efficacy in Adult cUTI/AP
The trial compares a new oral tebipenem with standard IV imipenem‑cilastatin to improve treatment options for adults with complicated urinary infections.
- Oral antibiotic effectiveness
- Comparison with established IV therapy
- Clinical cure and microbiological eradication
Conducted at Klinika Za Infektivne Bolesti Dr. Fran Mihaljevic in Zagreb, the research targets complicated urinary tract infection and acute pyelonephritis in hospitalized adults.
Pediatric Safety of Meropenem‑Vaborbactam
The study assesses the safety and tolerability of IV Vabomere in children diagnosed with complicated urinary infections.
- Safety profile in pediatric patients
- Pharmacokinetic evaluation of meropenem‑vaborbactam
- Dosing strategies for cUTI in children
Focused on complicated urinary tract infection and its severe form, acute pyelonephritis, the investigation aims to broaden therapeutic options for young patients at the Zagreb clinic.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 therapeutic areas and 15 of 30 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Bioversys S.A.S.1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 60 other sites in Croatia
Therapeutic Area Benchmark — Croatia
Select a therapeutic area to compare against other sites in Croatia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Croatia
Market Share
Country: Croatia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Klinika Za Infektivne Bolesti Dr. Fran Mihaljevic
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Oseltamivir and Drug Combinations in Hospitalized Patients with Acute Respiratory Tract Infection: A Randomized Adaptive Platform Trial | Universitair Medisch Centrum Utrecht | Phase III | Recruiting | Feb 2016 | — |
IMP list
lock Showing 1 of 30 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amoxicillin Sodium | 1 | Unknown | 2016-02-19 | 2016-02-19 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.